Bio-Techne (TECH) SEC Filings & 10K Form

$64.06
+1.40 (+2.23%)
(As of 04/26/2024 ET)

Recent Bio-Techne SEC Filings

DateFilerForm TypeView
04/05/2024
3:53 PM
Bio-Techne (Issuer)
Bohnen Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
2:03 PM
Bio-Techne (Subject)
Nusse Roeland (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
5:33 PM
Bio-Techne (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:34 PM
Bio-Techne (Issuer)
McManus Matthew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2024
5:35 PM
Bio-Techne (Issuer)
McManus Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:36 PM
Bio-Techne (Issuer)
Geist William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
5:30 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
8:46 AM
Bio-Techne (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/08/2024
5:32 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
5:13 PM
Bio-Techne (Issuer)
Hippel James (Reporting)
Form 4/A
12/14/2023
5:13 PM
Bio-Techne (Issuer)
Kelderman Kim (Reporting)
Form 4/A
12/14/2023
5:14 PM
Bio-Techne (Issuer)
Bohnen Shane (Reporting)
Form 4/A
12/14/2023
5:15 PM
Bio-Techne (Issuer)
Geist William (Reporting)
Form 4/A
11/09/2023
3:23 PM
Bio-Techne (Issuer)
Geist William (Reporting)
Form 4/A
11/07/2023
3:35 PM
Bio-Techne (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2023
5:34 PM
Bio-Techne (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
5:35 PM
Bio-Techne (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
5:35 PM
Bio-Techne (Issuer)
Geist William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:30 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
3:39 PM
BAUMGARTNER ROBERT V (Reporting)
Bio-Techne (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:40 PM
Bio-Techne (Issuer)
Nusse Roeland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:42 PM
Bio-Techne (Issuer)
KEEGAN JOSEPH D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:47 PM
Bio-Techne (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:49 PM
Bio-Techne (Issuer)
STEER RANDOLPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:50 PM
Bio-Techne (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2023
6:00 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
6:00 AM
Bio-Techne (Filer)
Form DEF 14A
09/13/2023
6:01 AM
Bio-Techne (Filer)
Form DEFA14A
09/13/2023
6:06 AM
Bio-Techne (Filer)
Form ARS
08/30/2023
3:14 PM
Bio-Techne (Subject)
Nusse Roeland (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
3:19 PM
Bio-Techne (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
3:20 PM
Bio-Techne (Issuer)
Bohnen Shane (Reporting)
Form 4/A
08/23/2023
3:30 PM
Bio-Techne (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/17/2023
3:24 PM
Bio-Techne (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
4:29 PM
Bio-Techne (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
4:31 PM
Bio-Techne (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
4:28 PM
Bio-Techne (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
5:30 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2023
4:27 PM
Bio-Techne (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
3:34 PM
Bio-Techne (Subject)
Kummeth Charles R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2023
5:38 PM
Bio-Techne (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
06/06/2023
1:29 PM
Bio-Techne (Subject)
Kummeth Charles R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2023
5:30 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TECH) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners